Payers have increasingly implemented a variety cost-containment measures to promote
sustainability in the pharmaceutical sector. This paper provides an assessment of a range of …

Objective Several EU countries are determining reimbursement prices of pharmaceuticals
by cross-referencing prices of foreign countries. Our objective is to quantify the theoretical …

Abstract Backgrounds Since 2012, the Korean government has introduced 46.5% price cut
for off-patent medicines in order to reign everescalating drug expenditure. This study sought …

The Competition is increasing day by day in Business arena and one who reacted timely
against these frequent changes can survive in the competition, same in the field of …

Rising pharmaceutical expenditure has become a major concern for policy makers in
Germany over recent years. Therefore, the pharmaceutical market has been increasingly …

Several European administrations have applied various mechanisms promoting cost
containment to stabilise their budgets for pharmaceutical expenditure. Since 2016, Greece …

To identify the influences on the diffusion of generics after patent expiry, we analyzed 65
generic entries using prescription data of a large German sickness fund between 2007 and …

To contain pharmaceutical spending, drug budgets have been introduced across health
systems. Apart from analyzing whether drug budgets fulfill their overall goal of reducing …

Zusammenfassung Das Lehr-und Forschungsgebiet» Management im Gesundheitswesen
«hat in den letzten Jahren deutlich an Bedeutung gewonnen. Es besteht in vielen Bereichen …

In this article, price changes for pharmaceuticals in Germany are modelled as a function of
regulation and competition. Changes in the regulatory environment, and in the competitive …